| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 1 security · may seek to influence control | ||||||
|
Bioforce Nanosciences Holdings, Inc.
13D
BFNH · 09064C206
|
79.6% |
9/4/2026
Event 4/22/2026
|
||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.